2024-11-27 19:39:09
Ascletis Announces Dosing of the First Patient in the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure
Corporate/ 2023-07-24
Ascletis Announces Dosing of the First P...

-- After the pre-Phase III clinical trial meeting with Center for Drug Evaluation (CDE) of China National Medical Products Administration (N...

ETANA HAS SECURED B ROUND FINANCING
Health/ 2023-07-22
ETANA HAS SECURED B ROUND FINANCING

JAKARTA,Indonesia,Sept. 28,2022-- PT Etana Biotechnologies Indonesia (Etana),an Indonesian biopharmaceutical company,has secured B round of ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release